| Structural definition of a conserved neutralization epitope on HIV-1 gp120 T Zhou, L Xu, B Dey, AJ Hessell, D Van Ryk, SH Xiang, X Yang, ... Nature 445 (7129), 732-737, 2007 | 970 | 2007 |
| Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses B Dey, DL Lerner, P Lusso, MR Boyd, JH Elder, EA Berger Journal of virology 74 (10), 4562-4569, 2000 | 282 | 2000 |
| Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking … K Salzwedel, ED Smith, B Dey, EA Berger Journal of virology 74 (1), 326-333, 2000 | 188 | 2000 |
| Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site … MT Esser, T Mori, I Mondor, QJ Sattentau, B Dey, EA Berger, MR Boyd, ... Journal of virology 73 (5), 4360-4371, 1999 | 184 | 1999 |
| Novel CD4-based bispecific chimeric antigen receptor designed for enhanced anti-HIV potency and absence of HIV entry receptor activity L Liu, B Patel, MH Ghanem, V Bundoc, Z Zheng, RA Morgan, ... Journal of virology 89 (13), 6685-6694, 2015 | 154 | 2015 |
| Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site B Dey, K Svehla, L Xu, D Wycuff, T Zhou, G Voss, A Phogat, ... PLoS pathogens 5 (5), e1000445, 2009 | 149 | 2009 |
| Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the CD4-bound state: antigenicity, biophysics, and immunogenicity B Dey, M Pancera, K Svehla, Y Shu, SH Xiang, J Vainshtein, Y Li, ... Journal of virology 81 (11), 5579-5593, 2007 | 131 | 2007 |
| Cdc37 is required for p60v-src activity in yeast B Dey, J Lightbody, F Boschelli Mol. Biol. Cell 7, 1405-1417, 1996 | 106 | 1996 |
| Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor B Dey, CS Del Castillo, EA Berger Journal of virology 77 (5), 2859-2865, 2003 | 104 | 2003 |
| The Ydj1 molecular chaperone facilitates formation of active p60v-src in yeast B Dey, A Caplan, F Boschelli Mol. Biol. Cell 7, 91-100, 1996 | 85 | 1996 |
| Structure− activity relationships in the binding of chemically derivatized CD4 to gp120 from human immunodeficiency virus H Xie, D Ng, SN Savinov, B Dey, PD Kwong, R Wyatt, AB Smith, ... Journal of medicinal chemistry 50 (20), 4898-4908, 2007 | 76 | 2007 |
| B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4 MNE Forsell, B Dey, A Mörner, K Svehla, S O'dell, CM Högerkorp, G Voss, ... PLoS pathogens 4 (10), e1000171, 2008 | 74 | 2008 |
| Human immunodeficiency virus type 1 env trimer immunization of macaques and impact of priming with viral vector or stabilized core protein A Mörner, I Douagi, MNE Forsell, C Sundling, P Dosenovic, S O'Dell, ... Journal of virology 83 (2), 540-551, 2009 | 70 | 2009 |
| Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti–human immunodeficiency virus potency and breadth with … MH Ghanem, S Bolivar-Wagers, B Dey, A Hajduczki, ... Cytotherapy 20 (3), 407-419, 2018 | 61 | 2018 |
| Interdomain stabilization impairs CD4 binding and improves immunogenicity of the HIV-1 envelope trimer P Zhang, J Gorman, H Geng, Q Liu, Y Lin, Y Tsybovsky, EP Go, B Dey, ... Cell Host & Microbe 23 (6), 832-844. e6, 2018 | 50 | 2018 |
| sCD4-17b bifunctional protein: extremely broad and potent neutralization of HIV-1 Env pseudotyped viruses from genetically diverse primary isolates LA Lagenaur, VA Villarroel, V Bundoc, B Dey, EA Berger Retrovirology 7, 1-13, 2010 | 43 | 2010 |
| Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies J Ingale, K Tran, L Kong, B Dey, K McKee, W Schief, PD Kwong, ... Journal of virology 88 (24), 14002-14016, 2014 | 41 | 2014 |
| Towards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infection B Dey, EA Berger Current Opinion in HIV and AIDS 10 (3), 207-213, 2015 | 27 | 2015 |
| The cerebellum enriched form of nuclear factor I is functionally different from ubiquitous nuclear factor I in glial cell specific gene regulation C Krebs, B Dey, G Kumar J. Neurochemistry 66, 1354-1361, 1996 | 16 | 1996 |
| Protein-based HIV-1 microbicides B Dey, L A Lagenaur, P Lusso Current HIV research 11 (7), 576-594, 2013 | 12 | 2013 |
